Keyword: Antisense Therapy : Search

System Upgrade on Tue, May 28th, 2024 at 2am (EDT)

Existing users will be able to log into the site and access content. However, E-commerce and registration of new users may not be available for up to 12 hours.
For online purchase, please visit us again. Contact us at customercare@wspc.com for any enquiries.

Advanced Search

SEARCH GUIDE

Results: 1 - 2of2

Follow results:

per page:

Sort: Relevance

Context for search term 1Search term 1*

All Dates

LastSelect static range

Custom Range

Select starting monthSelect starting year

Select ending monthSelect ending year

Search name	Searched On	Run search
Keyword: Optical Materials (20)	26 Mar 2025	Run
Keyword: Endpoint Security (1)	26 Mar 2025	Run
Keyword: Ladder Polyethers (1)	26 Mar 2025	Run
Keyword: Routing Protocols (9)	26 Mar 2025	Run
Keyword: Antisense Therapy (2)	26 Mar 2025	Run

articleNo Access
Special Feature
Asia-Pacific Biotech News30 Mar 2007
Preview Abstract
Drug Delivery in Cancer Therapy.
Transdermal Drug Delivery.
Nanotechnology and Drug Delivery.
Types of Drug Delivery Systems.
chapterNo Access
Chapter 9: Targeting Noncoding RNA for Treatment of Autism Spectrum Disorders
- Jessica DeWitt and
- Daniel B. Campbell
Frontiers in Autism Research03 Jun 2014
Preview Abstract
An entirely new area of pharmacology is developing from an understanding of endogenous functional long noncoding RNAs (lncRNAs). Potential treatment options for cancer, diabetes and HIV are derived from findings that specific lncRNAs, which regulate networks of genes, can be targeted to treat the disorders. Emerging evidence indicates that specific lncRNAs also contribute to autism spectrum disorder (ASD) risk. Here, we review this evidence and explore possible treatment advances for ASD based on inhibitory RNA-based therapies.

1